Linked Heterogeneity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linked Heterogeneity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linked Heterogeneity Today - Breaking & Trending Today

Black HFrEF Patients Fare Better With Empagliflozin

Published: December 21, 2022

Empagliflozin trial data from patients with heart failure with reduced ejection fraction signal more benefit in Black compared with White patients.

Source: medscape.com

Related Topics:

United StatesSubodh VermaUniversity Of TorontoAmerican Heart AssociationBoehringer IngelheimLinked HeterogeneityLinked Treatment Responses OnlyKansas City Cardiomyopathy QuestionnairePatients Also HadHeart FailureCardiovascular ImagingArdiac ImagingV ImagingEjection Fraction Ef Eft Ventricular Ejection Fraction Lvef Sglt2 InhibitorsOdium Glucose Transporter 2 InhibitorsOdium Glucose Co Transporter 2 InhibitorsSodium Glucose Cotransporter 2 InhibitorsDiabetes Mellitus Type 2Iabetes Mellitus Type IiType 2 DiabetesTravel Medicine